These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6351341)

  • 1. An improved method for washing of human platelets with prostacyclin.
    Radomski M; Moncada S
    Thromb Res; 1983 May; 30(4):383-9. PubMed ID: 6351341
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of prostacyclin in the separation from plasma and washing of human platelets.
    Vargas JR; Radomski M; Moncada S
    Prostaglandins; 1982 Jun; 23(6):929-45. PubMed ID: 6812168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
    MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
    Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of circulating prostacyclin.
    Haslam RJ; McClenaghan MD
    Nature; 1981 Jul; 292(5821):364-6. PubMed ID: 7019720
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults.
    Varela AF; Runge A; Ignarro LJ; Chaudhuri G
    Am J Obstet Gynecol; 1992 Dec; 167(6):1599-604. PubMed ID: 1471673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human platelets separated from blood by ADP-induced aggregation.
    Mohammad SF; Reddick RL; Mason RG
    Am J Pathol; 1975 Apr; 79(1):81-94. PubMed ID: 1124800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
    MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
    Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative insensitivity of epinephrine induced platelet aggregation to prostacyclin.
    Zahavi M; Zahavi J
    Thromb Res; 1986 Oct; 44(1):119-24. PubMed ID: 3538494
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
    Best LC; Martin TJ; Russell RG; Preston FE
    Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
    [No Abstract]   [Full Text] [Related]  

  • 13. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin.
    Hassall DG; Owen JS; Bruckdorfer KR
    Biochem J; 1983 Oct; 216(1):43-9. PubMed ID: 6360159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Musiał J; Pietoń R; Mruk J
    Pharmacol Res Commun; 1978 Jun; 10(6):545-56. PubMed ID: 358212
    [No Abstract]   [Full Text] [Related]  

  • 15. An ultrastructural study of stored human platelets after washing using prostacyclin.
    Read NG; Radomski MW; Goodwin DA; Moncada S
    Br J Haematol; 1985 Jun; 60(2):305-14. PubMed ID: 3890933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A; Stierle A; Anton R; Cazenave JP
    Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E deficiency: its effect on platelet-vascular interaction in various pathologic states.
    Stuart MJ
    Ann N Y Acad Sci; 1982; 393():277-88. PubMed ID: 6756257
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of prostacyclin and albumin on platelet loss during in vitro simulation of extracorporeal circulation.
    Addonizio VP; Macarak J; Nicolaou KC; Edmunds LH; Colman RW
    Blood; 1979 Jun; 53(6):1033-42. PubMed ID: 375998
    [No Abstract]   [Full Text] [Related]  

  • 19. Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation.
    Buttrick PM; Forscher CA; Sussman II; Mueller HS
    Am Heart J; 1985 Jun; 109(6):1258-63. PubMed ID: 2988323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is prostacyclin a physiologically important circulating anti-platelet agent?
    Steer ML; MacIntyre DE; Levine L; Salzman EW
    Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.